Compare EVEX & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVEX | THQ |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | 198 | N/A |
| Industry | Aerospace | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.9M | 731.8M |
| IPO Year | N/A | N/A |
| Metric | EVEX | THQ |
|---|---|---|
| Price | $3.03 | $18.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.88 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 115.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11,676.47 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.34 | $15.14 |
| 52 Week High | $7.70 | $20.39 |
| Indicator | EVEX | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 52.77 | 55.41 |
| Support Level | $2.86 | $18.19 |
| Resistance Level | $3.18 | $19.39 |
| Average True Range (ATR) | 0.22 | 0.27 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 50.60 | 57.56 |
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.